Notice Number: NOT-AI-20-012
Key Dates
Release Date: November 15, 2019
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Aging (NIA)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for PAR-18-630, "Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)" has been extended. This FOA now expires on March 8, 2020.
In Part 1, under Key Dates, each of the specified date types now have one additional or new date.
Application Due Date(s)
New Dates April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019; March 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
April 10, 2018; December 7, 2018; March 7, 2019; December 6, 2019; March 9, 2020, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
July 2018; March 2019; June 2019; March 2020; June 2020
Advisory Council Review
October 2018; May 2019; August/September 2019; May 2020; August 2020
Earliest Start Date
December 2018; July 2019; September 2019; July 2020; September 2020
Expiration Date
March 10, 2020
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Sergei Romashkan, M.D., Ph.D.
National Institute on Aging (NIA)
Telephone: 301-435-3047
Email: [email protected]
Kenneth Santora, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2933
Email: [email protected]